Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Rural Victorians have higher PSA levels and disease severity at diagnosis, linked data study finds

New primary care data show abnormal PSA tests often precede diagnosis by months; targeted action in general practice could reduce rural–metropolitan disparities.

04 Feb 2026

New primary care data show abnormal PSA tests often precede diagnosis by months; targeted action in general practice could reduce rural–metropolitan disparities.

Rural Victorians diagnosed with prostate cancer have higher prostate‑specific antigen (PSA) levels at diagnosis than metropolitan patients, and experience slightly longer waits to diagnosis, a new study from the VCCC Alliance Data Connect program has found. 

The study, published in late 2025, analysed 2,470 men diagnosed in Victoria between 2010 and 2022 using linked primary care data and cancer registry data. Of the 2,470 men, 52 per cent lived in rural areas and 48 per cent in metropolitan.

The study found rural patients were more likely to have high‑grade disease (24 per cent compared to 14 per cent) and were almost twice as likely to have higher PSA levels at diagnosis (16 per cent rural vs eight per cent metropolitan). These higher levels of PSA at diagnosis were associated with poorer five-year survival.

Rural patients were more likely to have a delay from first abnormal PSA result to cancer diagnosis, averaging eight months compared to seven months in metropolitan patients. 

Why this matters

The data suggest that abnormal PSA results are frequently detectable many months before diagnosis, even in patients with significantly elevated PSA levels. 

“Our findings show there is substantial variation in tumour characteristics and PSA levels pre-diagnosis between rural and metropolitan areas which could contribute to disparities in prostate cancer survival,” lead author Dr Meena Rafiq said. 

“This highlights a clear opportunity in primary care to close gaps in prostate cancer diagnosis,” she said. “Targeted interventions to identify and act on abnormal PSA results — especially in rural settings — could help detect cancers earlier and improve outcomes for rural Victorians.”

About the data 

The Centre for Victorian Data Linkage (CVDL) linked the VCR data to the National Death Index dataset, and the Patron (Primary Care Audit, Teaching and Research Open Network) primary care dataset. This linkage is made possible by the VCCC Alliance Data Connect program. The Patron primary care dataset is managed by the Department of General Practice and Primary Care at the University of Melbourne. It contains data from over 130 Victorian general practices on 1.8 million patients between 1996 and 2022. Data from the 2016 Australian Bureau of Statistics (ABS) Census was used to compare the study cohort with the broader Victorian population.

 

  • University of Melbourne
  • VCCC Alliance

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.